Perspective Therapeutics, Inc. · AMEX:CATX
Chen Yu reported a 6.90% stake in Perspective Therapeutics, Inc. (Schedule 13G)
Event Feb 3, 2026 · Filed Feb 6, 2026
Chen Yu reported a 6.90% stake in Perspective Therapeutics, Inc., 7,915,567 shares, as a passive investor on Feb 3, 2026. Filed Feb 6, 2026 (Schedule 13G).
- Stake
- 6.90%
- Shares
- 7,915,567
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 3.50% | 3,957,784 |
| TCG Crossover Fund II, L.P. | 3.50% | 3,957,784 |
| TCG Crossover GP III, LLC | 3.50% | 3,957,783 |
| TCG Crossover Fund III, L.P. | 3.50% | 3,957,783 |
| Chen Yu | 6.90% | 7,915,567 |
Source
Related
- Perspective Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Perspective Therapeutics, Inc. shareholders
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 4, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 4, 2026